Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31719 | 149 | 40.2 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
343 | 3 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE SYNTHASE | 36678 |
295 | 2 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 18821 |
31719 | 1 | ST EUGENIO CTO A ALESINI HOSP//MASSACHUSETTS GEN HOSPSHRINERS HOSP CHILDREN//ABLUMINAL MEMBRANE | 149 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ST EUGENIO CTO A ALESINI HOSP | address | 409873 | 1% | 100% | 2 |
2 | MASSACHUSETTS GEN HOSPSHRINERS HOSP CHILDREN | address | 230550 | 2% | 38% | 3 |
3 | ABLUMINAL MEMBRANE | authKW | 204936 | 1% | 100% | 1 |
4 | AKT AS160 | authKW | 204936 | 1% | 100% | 1 |
5 | CELL THER Y IMMUNOL PL | address | 204936 | 1% | 100% | 1 |
6 | CLIN ANAL SCI | address | 204936 | 1% | 100% | 1 |
7 | CLIN BIOCHEM PHARMCOL | address | 204936 | 1% | 100% | 1 |
8 | CLIN HOSP ZARAGOZA | address | 204936 | 1% | 100% | 1 |
9 | CREB ERK | authKW | 204936 | 1% | 100% | 1 |
10 | CULTURED CELL DIFFERENTIATION | authKW | 204936 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 975 | 32% | 0% | 47 |
2 | Cell Biology | 120 | 16% | 0% | 24 |
3 | Biochemistry & Molecular Biology | 108 | 26% | 0% | 38 |
4 | Medical Laboratory Technology | 78 | 4% | 0% | 6 |
5 | Physiology | 77 | 9% | 0% | 13 |
6 | Medicine, Research & Experimental | 63 | 9% | 0% | 13 |
7 | Nutrition & Dietetics | 36 | 5% | 0% | 7 |
8 | Cell & Tissue Engineering | 27 | 1% | 0% | 2 |
9 | Pharmacology & Pharmacy | 16 | 9% | 0% | 13 |
10 | Cardiac & Cardiovascular System | 16 | 5% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ST EUGENIO CTO A ALESINI HOSP | 409873 | 1% | 100% | 2 |
2 | MASSACHUSETTS GEN HOSPSHRINERS HOSP CHILDREN | 230550 | 2% | 38% | 3 |
3 | CELL THER Y IMMUNOL PL | 204936 | 1% | 100% | 1 |
4 | CLIN ANAL SCI | 204936 | 1% | 100% | 1 |
5 | CLIN BIOCHEM PHARMCOL | 204936 | 1% | 100% | 1 |
6 | CLIN HOSP ZARAGOZA | 204936 | 1% | 100% | 1 |
7 | EDIFICIO CIFA | 204936 | 1% | 100% | 1 |
8 | HOSP JM VARGAS | 204936 | 1% | 100% | 1 |
9 | INSERM CJF 94 02CHI POISSY | 204936 | 1% | 100% | 1 |
10 | INSERM CJF9402 | 204936 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 12188 | 6% | 1% | 9 |
2 | REVISTA LATINOAMERICANA DE HIPERTENSION | 2089 | 1% | 1% | 1 |
3 | ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS | 1451 | 1% | 1% | 1 |
4 | BIOLOGY OF SPORT | 1107 | 1% | 0% | 2 |
5 | DIABETES | 829 | 5% | 0% | 7 |
6 | CLINICAL BIOCHEMISTRY | 634 | 3% | 0% | 4 |
7 | METABOLISM-CLINICAL AND EXPERIMENTAL | 572 | 3% | 0% | 5 |
8 | INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH | 558 | 1% | 0% | 1 |
9 | CLINICAL LIPIDOLOGY | 534 | 1% | 0% | 1 |
10 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 499 | 3% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GHASEMI, A , ZAHEDIASL, S , AZIZI, F , (2013) ELEVATED NITRIC OXIDE METABOLITES ARE ASSOCIATED WITH OBESITY IN WOMEN.ARCHIVES OF IRANIAN MEDICINE. VOL. 16. ISSUE 9. P. 521-525 | 10 | 40% | 5 |
2 | LINSCHEID, P , SEBOEK, D , ZULEWSKI, H , SCHERBERICH, A , BLAU, N , KELLER, U , MULLER, B , (2006) CYTOKINE-INDUCED METABOLIC EFFECTS IN HUMAN ADIPOCYTES ARE INDEPENDENT OF ENDOGENOUS NITRIC OXIDE.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 290. ISSUE 6. P. E1068-E1077 | 14 | 32% | 8 |
3 | CANOVA, N , LINCOVA, D , FARGHALI, H , (2005) INCONSISTENT EFFECT OF NITRIC OXIDE ON LIPOLYSIS IN ISOLATED RAT ADIPOCYTES.PHYSIOLOGICAL RESEARCH. VOL. 54. ISSUE 4. P. 387-393 | 8 | 57% | 7 |
4 | CANOVA, NK , LINCOVA, D , KMONICKOVA, E , KAMENIKOVA, L , FARGHALI, H , (2006) NITRIC OXIDE PRODUCTION FROM RAT ADIPOCYTES IS MODULATED BY BETA(3)-ADRENERGIC RECEPTOR AGONISTS AND IS INVOLVED IN A CYCLIC AMP-DEPENDENT LIPOLYSIS IN ADIPOCYTES.NITRIC OXIDE-BIOLOGY AND CHEMISTRY. VOL. 14. ISSUE 3. P. 200-211 | 12 | 34% | 13 |
5 | HEMMRICH, K , PAUL, NE , PALLUA, N , (2012) THE NITRIC OXIDE SYSTEM - CURE FOR SHORTCOMINGS IN ADIPOSE TISSUE ENGINEERING?.JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. VOL. 6. ISSUE . P. S1-S3 | 12 | 29% | 0 |
6 | TEHRANI, F , BEHBOUDI-GANDEVANI, S , GHASEMI, A , AZIZI, F , (2015) MENOPAUSE STATUS AS THE MAIN FACTOR EXPLAINING THE GENDER DIFFERENCES OF SERUM NITRIC OXIDE CONCENTRATIONS IN MIDDLE-AGED POPULATION.ARCHIVES OF GYNECOLOGY AND OBSTETRICS. VOL. 291. ISSUE 1. P. 159 -163 | 7 | 41% | 2 |
7 | ROPELLE, ER , PAULI, JR , CINTRA, DE , DA SILVA, AS , DE SOUZA, CT , GUADAGNINI, D , CARVALHO, BM , CARICILLI, AM , KATASHIMA, CK , CARVALHO, MA , ET AL (2013) TARGETED DISRUPTION OF INDUCIBLE NITRIC OXIDE SYNTHASE PROTECTS AGAINST AGING, S-NITROSATION, AND INSULIN RESISTANCE IN MUSCLE OF MALE MICE.DIABETES. VOL. 62. ISSUE 2. P. 466-470 | 8 | 35% | 18 |
8 | ENGELI, S , JANKE, J , GORZELNIAK, K , BOHNKE, J , GHOSE, N , LINDSCHAU, C , LUFT, FC , SHARMA, AM , (2004) REGULATION OF THE NITRIC OXIDE SYSTEM IN HUMAN ADIPOSE TISSUE.JOURNAL OF LIPID RESEARCH. VOL. 45. ISSUE 9. P. 1640-1648 | 11 | 31% | 59 |
9 | GHASEMI, A , ZAHEDIASL, S , AZIZI, F , (2010) REFERENCE VALUES FOR SERUM NITRIC OXIDE METABOLITES IN AN ADULT POPULATION.CLINICAL BIOCHEMISTRY. VOL. 43. ISSUE 1-2. P. 89-94 | 8 | 35% | 11 |
10 | BAHADORAN, Z , MIRMIRAN, P , GHASEMI, A , AZIZI, F , (2015) SERUM NITRIC OXIDE METABOLITES ARE ASSOCIATED WITH THE RISK OF HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE IN WOMEN: TEHRAN LIPID AND GLUCOSE STUDY.NITRIC OXIDE-BIOLOGY AND CHEMISTRY. VOL. 50. ISSUE . P. 52 -57 | 10 | 25% | 0 |
Classes with closest relation at Level 1 |